INDV Indivior Pharmaceuticals, Inc. Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
16:42
Sep 16
r/wallstreetbets
70% INDV on kratom ban, dividend
Author is roughly 70% of their portfolio in INDV since late May 2025, arguing that the DEA's scheduling of kratom alkaloids (with 7-OH next) will push users toward Suboxone, which INDV produces. The catalyst is the anticipated 7-OH ban the author has been waiting for since July 2025, plus an $8.47 per share dividend. The author notes the merger with another bio company has skewed the thesis but is still holding. Main risk is the merger complicating the original ban-driven thesis.
INDV Indivior Pharmaceuticals, Inc. Long 1ST — —

About INDV Investor Commentary

Across the available history and selected sources, Buzzberg tracks INDV (Indivior Pharmaceuticals, Inc.) across 2 sources: 1 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 50% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: u/1-800-YOLO.